We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Four-Drug Combination Therapy With Zidovudine, Lamivudine, 1592U89 (Abacavir), and 141W94 (Amprenavir) in HIV-Infected Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00006617
Recruitment Status : Completed
First Posted : August 31, 2001
Last Update Posted : May 15, 2015
Glaxo Wellcome
Information provided by:
National Institute of Allergy and Infectious Diseases (NIAID)

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2007
  Study Completion Date : June 2007